Search results for "Germany"

showing 10 items of 1172 documents

Reimbursement of radiotherapy in Germany.

2017

Reimbursement of radiotherapy in Germany is mainly based on a certain fixed fee for treatment planning and patient set up in addition to payment per fraction. This applies to outpatient care for patients with public health insurance or private health insurance. Payment per fraction has a considerable influence on reimbursement of inpatients as well. The advantage of payment per fraction is the simplicity and transparency. The disadvantage is an inadequate reimbursement for new treatment modalities like hypofractionation or stereotactic body radiotherapy.

medicine.medical_specialtyTransparency (market)media_common.quotation_subjectmedicine.medical_treatmentReimbursement Mechanisms03 medical and health sciences0302 clinical medicineAmbulatory careGermanyMedicineHumansRadiology Nuclear Medicine and imaging030212 general & internal medicineRadiation treatment planningIntensive care medicinehealth care economics and organizationsDisadvantageReimbursementmedia_commonRadiotherapybusiness.industryPaymentRadiation therapyOncology030220 oncology & carcinogenesisbusinessStereotactic body radiotherapyCancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
researchProduct

Substance P is upregulated in the serum of patients with chronic spontaneous urticaria.

2014

medicine.medical_specialtyUrticariaMEDLINESubstance PDermatologyAnxietySubstance PBiochemistrySeverity of Illness Indexchemistry.chemical_compoundText miningQuality of lifeDownregulation and upregulationInternal medicineGermanySeverity of illnessMedicineHumansMolecular Biologybusiness.industryDepressionDisease progressionCell BiologyUp-RegulationMulticenter studychemistryChronic DiseaseDisease ProgressionQuality of LifebusinessBiomarkersThe Journal of investigative dermatology
researchProduct

Anaesthesia in Central Europe.

1978

medicine.medical_specialtybusiness.industryAnesthesiologyAnesthesiaAnesthesiologyGermanymedicineGeneral MedicinebusinessResearch ArticleJournal of the Royal Society of Medicine
researchProduct

Hepatitis C virus: Current steps toward elimination in Germany and barriers to reaching the 2030 goal

2021

Abstract Hepatitis C virus (HCV) affects over 70 million people globally, with an estimated 399 000 HCV‐related deaths in 2016. The World Health Organization (WHO) has set a goal to eliminate HCV by 2030. Despite the availability of direct‐acting antivirals—highly effective and well‐tolerated therapies for HCV—many patients infected with HCV in Germany have not initiated treatment, including a majority of those who are aware of their positive diagnosis. Barriers to screening, diagnosis, and treatment are major factors taking many countries off track for HCV elimination by 2030. Identifying country‐specific barriers and challenges, particularly in at‐risk populations such as people who injec…

medicine.medical_specialtybusiness.industryHepatitis C virusbarriersRReviewsvirus diseasesReviewGeneral MedicineHepatitis Chigh‐risk groupsmedicine.diseasemedicine.disease_causeHepatitis CHcv eliminationWorld healthdigestive system diseasesMen who have sex with meneliminationFamily medicineGermanyMedicineMedicinebusinessGood practiceHealth Science Reports
researchProduct

Towards nation-wide cancer registration in the Federal Republic of Germany

1995

medicine.medical_specialtybusiness.industryPublic healthIncidence (epidemiology)Federal republic of germanyCancer registrationHematologyWest germanyOncologyFamily medicineEpidemiologyMedicinebusinessCohort studyAnnals of Oncology
researchProduct

Franz Kuhn, his contribution to anaesthesia and emergency medicine.

2001

Franz Kuhn (1866-1929), a German surgeon, made a significant practical and scientific contribution towards the development of modern anaesthesia and emergency medicine. He developed modern, scientifically based concepts in close correlation to practical inventions for every day use. All of his studies and developments were patient orientated and led to remarkable improvements in patient safety. Kuhn was a major protagonist of endotracheal intubation, perfected his flexo-metallic endotracheal tubes, worked on different techniques of intubating the trachea, applied positive pressure to the lungs during thoracic surgery and developed anaesthesia machines. In the early 20th century, he wrote se…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentHistory 19th CenturyRegional anaesthesiaEndotracheal intubationEquipment DesignEmergency Nursingmedicine.diseasePneumothoraxCardiothoracic surgeryGermanyAnesthesiaEmergency medicineIntubation IntratrachealEmergency MedicineHumansMedicineIntubationAnesthesiaIn patientCardiology and Cardiovascular MedicinebusinessResuscitation
researchProduct

Epidemiologie von Infektionskrankheiten bei Kindern in den alten Ländern der Bundesrepublik Deutschland*

1991

This study was done to describe the epidemiology of infectious diseases in children living in the old countries of the Federal Republic of Germany. After an intensive search for literature, data about notifiable diseases, data from insurance agencies and a random test from 700 charts of a general pediatrician were reviewed and analysed in a standardized way for their validity. No single review article on this topic was found. Estimates about the frequency of some specific infectious diseases as well as data about notifiable diseases proved to be unreliable and not useful from a scientific point of view. Published insurance data suggested, that infectious diseases may contribute comparativel…

medicine.medical_specialtyeducation.field_of_studybusiness.industryInfectious disease (medical specialty)Family medicinePediatrics Perinatology and Child HealthPopulationEpidemiologymedicineFederal republic of germanybusinesseducationKlinische Pädiatrie
researchProduct

Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancer

2007

Abstract Background. Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) contribute to the invasiveness of many carcinomas. Here, we studied a possible association between cytosolic uPA and PA-1 concentrations in tumor tissue with prognosis in patients with endometrial cancer. Methods. Cytosolic concentrations of uPA and PAI-1 were determined in 69 primary endothelial adenocarcinomas using an enzyme-linked immunoassay (ELISA). A possible influence of uPA and PAI-1 was studied by multivariate Cox regression adjusting for the established clinical prognostic factors FIGO-stage, grading, depth of invasion, diabetes mellitus and age. Results. Both uPA ( …

medicine.medical_specialtymedicine.drug_classAdenocarcinomaDisease-Free SurvivalMetastasisPredictive Value of TestsGermanyInternal medicineDiabetes mellitusPlasminogen Activator Inhibitor 1Progesterone receptorBiomarkers TumormedicineHumansNeoplasm StagingUrokinasebusiness.industryProportional hazards modelEndometrial cancerObstetrics and GynecologyMiddle AgedPrognosismedicine.diseaseSurvival AnalysisUrokinase-Type Plasminogen ActivatorEndometrial NeoplasmsEndocrinologyOncologyEstrogenFemalebusinessPlasminogen activatormedicine.drugGynecologic Oncology
researchProduct

Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany—Updated series of 120 cases

2020

Background Idarucizumab is a monoclonal antibody fragment with high affinity for dabigatran reversing its anticoagulant effects within minutes. Thereby, patients with acute ischemic stroke who are on dabigatran treatment may become eligible for thrombolysis with recombinant tissue-type plasminogen activator (rt-PA). In patients on dabigatran with intracerebral hemorrhage idarucizumab could prevent lesion growth. Aims To provide insights into the clinical use of idarucizumab in patients under effective dabigatran anticoagulation presenting with signs of acute ischemic stroke or intracranial hemorrhage. Methods Retrospective data collected from German neurological/neurosurgical departments ad…

medicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentMedizinAntibodies Monoclonal HumanizedAntithrombinsBrain IschemiaDabigatranGermanyInternal medicinemedicineHumansThrombolytic Therapyddc:610Ischemic StrokeRetrospective StudiesIntracerebral hemorrhagebusiness.industryAnticoagulantWarfarinIdarucizumabAtrial fibrillationThrombolysisVitamin K antagonistmedicine.diseaseDabigatranStrokeNeurologyCardiologybusinessIntracranial Hemorrhagesmedicine.drugInternational Journal of Stroke
researchProduct

Inguinal hernia repair in German military hospitals.

2005

ABSTRACT The inguinal hernia repair continues to be the most common operation in general surgery. Discussing the latest scientific findings, we have prepared this article to present a state-of-the-art approach to the inguinal hernia repair. This approach is used for discussing the general principles of hernia repair in German military hospitals. Quality assurance requires that all hernias be classified during surgery on the basis of a standardized approach for an objective comparison of treatment and outcomes. Our approach to hernia repair considers the age of the patient, the diameter and location of the hernia and whether or not the herniation is recurrent. The Shouldice technique perform…

medicine.medical_specialtymedicine.medical_treatmentEndoscopic surgeryHernia InguinalHospitals MilitaryMilitary medicineGermanyMedicineHumansMinimally Invasive Surgical ProceduresLocal anesthesiaHerniaMilitary Medicinemedicine.diagnostic_testbusiness.industryPublic Health Environmental and Occupational HealthGeneral MedicineHernia repairmedicine.diseasedigestive system diseasesSurgeryEndoscopystomatognathic diseasesInguinal herniasurgical procedures operativebusinessMilitary medicine
researchProduct